Gianpietro Dotti

25PUBLICATIONS
92CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)NanomaterialsTissue engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Dec 23, 2025
Correction: Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.

Raffaella De Maria, Chiara Donini, Sonia Capellero

|Dec 18, 2025
Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery.

Yixin Wang, Edikan Ogunnaike, Huan Yang

|Oct 21, 2025
Facts and Hopes of Chimeric Antigen Receptor-Redirected NK T Cells.

Amy N Courtney, Xin Zhou, Gengwen Tian

|Sep 13, 2025
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.

Raffaella De Maria, Chiara Donini, Sonia Capellero

|Jul 18, 2025
The landscape of CAR-engineered innate immune cells for cancer immunotherapy.

Ourania Tsahouridis, Max Xu, Feifei Song

|May 27, 2025
B7-H3 and CSPG4 co-targeting as Pan-CAR-T cell treatment of triple-negative breast cancer.

Simone Stucchi, Roberto Borea, Susana Garcia-Recio

Pageof 5

Frequent Collaborators

5 joint publications

Zhen Gu

4 joint publications

Mark Woodcock

3 joint publications

Paolo Dellabona

3 joint publications

Frances S Ligler